TacroBell SR cap.

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

Kidney Transplant

Phase 4

Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients

CompletedNCT03749356

Chong Kun Dang PharmaceuticalKidney Transplant

Start: 2018-09-05End: 2020-12-04Updated: 2021-01-05

Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM)

Chong Kun Dang PharmaceuticalKidney Transplant

Start: 2018-12-17End: 2020-11-30Target: 184Updated: 2020-01-13